Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sichuan Kelun Pharmaceutical Co Ltd (002422) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7879
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compound amino acid injection, alanyl glutamine injection, compound amino acids, fat emulsion injection, vitamin c and glucose injection, vitamin c and sodium chloride injection, among others. It also offers products to serve parenteral nutrition, digestive system, cardiovascular, antipsychotic, respiratory system, anti-pathogenic microorganisms, and APIs and intermediates. The company is also involved in research and development of pharmaceutical products. Kelun is headquartered in Chengdu, Sichuan, China.

Sichuan Kelun Pharmaceutical Co Ltd (002422) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deal Details 10
Debt Offering 10
Sichuan Kelun Pharma Raises USD111.2 Million in Public Offering of 5.65% 2018 Second Tranche Notes 10
Sichuan Kelun Pharma Raises USD79 Million in Public Offering of 6.2% 2018 First Tranche Notes Due 2021 11
Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 12
Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 13
Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 14
Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 15
Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 16
Sichuan Kelun Pharmaceutical Co Ltd – Key Competitors 17
Sichuan Kelun Pharmaceutical Co Ltd – Key Employees 18
Sichuan Kelun Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Affiliate 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Key Facts, 2017 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sichuan Kelun Pharmaceutical Co Ltd, Deals By Market, 2012 to YTD 2018 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sichuan Kelun Pharma Raises USD111.2 Million in Public Offering of 5.65% 2018 Second Tranche Notes 10
Sichuan Kelun Pharma Raises USD79 Million in Public Offering of 6.2% 2018 First Tranche Notes Due 2021 11
Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 12
Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 13
Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 14
Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 15
Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 16
Sichuan Kelun Pharmaceutical Co Ltd, Key Competitors 17
Sichuan Kelun Pharmaceutical Co Ltd, Key Employees 18
Sichuan Kelun Pharmaceutical Co Ltd, Subsidiaries 19
Sichuan Kelun Pharmaceutical Co Ltd, Affiliate 20

List of Figures
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sichuan Kelun Pharmaceutical Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of California Berkeley-製薬・医療分野:企業M&A・提携分析
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • Tourism Holdings Limited:企業の戦略・SWOT・財務分析
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Biologic Products Inc (CBPO):製薬・医療:M&Aディール及び事業提携情報
    Summary China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic pro …
  • Dowa Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Olympus America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Olympus America Inc (Olympus America), a subsidiary of Olympus Corporation is medical device company that designs, develops and manufactures medical and surgical products, industrial measurement and imaging instruments, life science imaging systems, and cameras and audio products. The compan …
  • Eagle Bancorp Inc:企業の戦略・SWOT・財務分析
    Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NeuStar, Inc.:企業の戦略的SWOT分析
    NeuStar, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, …
  • Sequa Petroleum NV:石油・ガス:M&Aディール及び事業提携情報
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company that develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Kazakhstan, North Western Europe and Sub Saharan Africa. Its Kazakhstan exploration site is located in Aksai block …
  • Anworth Mortgage Asset Corp (ANH):企業の財務・戦略的SWOT分析
    Summary Anworth Mortgage Asset Corp (Anworth) is a financial service provider that provides mortgage real estate investment services. The company invests in mortgage-backed securities on a leveraged basis. It operates through agency credit-backed securities and non-agency credit-backed securities. A …
  • KAMCO Investment Co KSCP (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Co KSCP (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kerecis ehf:製品パイプライン分析
    Summary Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura m …
  • AT&T Inc:戦略・SWOT・企業財務分析
    AT&T Inc - Strategy, SWOT and Corporate Finance Report Summary AT&T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Lululemon Athletica, Inc. (LULU):企業の財務・戦略的SWOT分析
    Lululemon Athletica, Inc. (LULU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tokyo Gas Co., Ltd.:企業の戦略・SWOT・財務分析
    Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • UCB Inc-製薬・医療分野:企業M&A・提携分析
    Summary UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metad …
  • Pluspetrol SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Pluspetrol SA (Pluspetrol), a subsidiary of Pluspetrol Resources Corporation N.V. is an oil and gas company that produces oil and gas products. The company’s products include LPG, natural gas, crude oil, liquid fuel, liquid gas and others. It explores and develops oil and gas reserves based …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆